Inactivation of the Ecs ABC Transporter of Staphylococcus aureus Attenuates Virulence by Altering Composition and Function of Bacterial Wall by Jonsson, Ing-Marie et al.
Inactivation of the Ecs ABC Transporter of
Staphylococcus aureus Attenuates Virulence by Altering
Composition and Function of Bacterial Wall
Ing-Marie Jonsson2, Jarmo T. Juuti1, Patrice Franc¸ois3, Rana AlMajidi1, Milla Pietia¨inen1, Myriam Girard3,
Catharina Lindholm2, Manfred J. Saller4, Arnold J. M. Driessen4, Pentti Kuusela5,6, Maria Bokarewa2,
Jacques Schrenzel3, Vesa P. Kontinen1,5*
1Antimicrobial Resistance Unit, Department of Infectious Disease Surveillance and Control, National Institute for Health and Welfare (THL), Helsinki, Finland, 2Department
of Rheumatology and Inflammation Research, University of Gothenburg, Go¨teborg, Sweden, 3Genomic Research Laboratory, Service of Infectious Diseases, University
Hospitals of Geneva, University of Geneva, Geneva, Switzerland, 4Molecular Microbiology, Groningen Biomolecular Sciences and Biotechnology Institute, Kluyver Centre
for the Genomics of Industrial Fermentations and the Zernike Institute of Advanced Materials, University of Groningen, Haren, The Netherlands, 5Department of
Bacteriology and Immunology, Haartman Institute, University of Helsinki, Helsinki, Finland, 6Division of Clinical Microbiology, Helsinki University Central Hospital
Laboratory, Helsinki, Finland
Abstract
Background: Ecs is an ATP-binding cassette (ABC) transporter present in aerobic and facultative anaerobic Gram-positive
Firmicutes. Inactivation of Bacillus subtilis Ecs causes pleiotropic changes in the bacterial phenotype including inhibition of
intramembrane proteolysis. The molecule(s) transported by Ecs is (are) still unknown.
Methodology/Principal Findings: In this study we mutated the ecsAB operon in two Staphylococcus aureus strains, Newman
and LS-1. Phenotypic and functional characterization of these Ecs deficient mutants revealed a defect in growth, increased
autolysis and lysostaphin sensitivity, altered composition of cell wall proteins including the precursor form of staphylokinase
and an altered bacterial surface texture. DNA microarray analysis indicated that the Ecs deficiency changed expression of
the virulence factor regulator protein Rot accompanied by differential expression of membrane transport proteins,
particularly ABC transporters and phosphate-specific transport systems, protein A, adhesins and capsular polysaccharide
biosynthesis proteins. Virulence of the ecs mutants was studied in a mouse model of hematogenous S. aureus infection.
Mice inoculated with the ecs mutant strains developed markedly milder infections than those inoculated with the wild-type
strains and had consequently lower mortality, less weight loss, milder arthritis and decreased persistence of staphylococci in
the kidneys. The ecs mutants had higher susceptibility to ribosomal antibiotics and plant alkaloids chelerythrine and
sanguinarine.
Conclusions/Significance: Our results show that Ecs is essential for staphylococcal virulence and antimicrobial resistance
probably since the transport function of Ecs is essential for the normal structure and function of the cell wall. Thus targeting
Ecs may be a new approach in combating staphylococcal infection.
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Introduction
The increased bacterial resistance to most or even all current
antibiotics is a threat that necessitates development of new
molecules with novel targets and/or modes of action [1]. Cell
components which are dispensable for growth but indispensable
for virulence and pathogenesis constitute therefore an interesting
class of potential candidates. In particular, bacterial membrane
proteins, including transporters, represent a wide repertoire of
likely antimicrobial targets for developing such new therapies.
Bacterial ATP-binding cassette (ABC) transporters are involved in
the uptake or secretion of a large variety of different biomolecules,
nutrients, antimicrobial agents or ions across the cytoplasmic
membrane. Some of these transporters are involved in virulence
and may represent appropriate antimicrobial targets [2] as
exemplified by the iron uptake systems [3–5]. The basic structure
of ABC transporters, independently of whether they are exporters
or importers, consists of a transmembrane permease domain and a
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cytoplasmic ATP-binding domain associated with the permease.
Both, the permease domain and the ATP-binding domain are
homo- or heterodimers, and depending on the transporter,
encoded by 1 to 4 different genes. Additionally, nearly all bacterial
importers also have a periplasmic high-affinity solute-binding
component. The ATP-binding domain hydrolyzes ATP and
energizes the molecular transport.
Ecs is an as yet poorly characterized ABC transporter. It is
present in aerobic and facultative anaerobic Gram-positive
Firmicutes, while no Ecs has been detected with amino acid
sequence homology surveys from Actinobacteria, obligatory
Gram-positive anaerobes or Gram-negative bacteria. Ecs was
originally identified in Bacillus subtilis in a mutant screen for
decreased secretion of overexpressed a-amylase [6,7]. Character-
ization of B. subtilis ecs mutants showed that secretion of
overexpressed extracellular proteins was reduced and signal
peptides were inefficiently processed in the mutants due to a
defect in the late stage of secretion [8,9]. The defect in signal
peptide processing was partially suppressed by overexpressing a
type I signal peptidase [9]. In addition to the secretion defect, ecs
mutants are defective in transformation competence [7] and
biofilm formation [10]. Recently it was shown that Ecs influences
intramembrane proteolysis through the RasP protease [11]. On
the other hand, inactivation of RasP causes a protein secretion
defect similar to that of ecs mutant [11], suggesting that the
impaired secretion is a result of the inhibition of intramembrane
proteolysis. The ecsA and ecsB genes encode the homodimeric
ATP-binding and permease domains of Ecs, respectively. It is still
unknown which molecule(s) Ecs transport(s) and whether it
functions as an exporter or an importer. The inhibition of
intramembrane proteolysis suggests that Ecs may have a ‘‘cleaning
function’’ in the membrane, e.g. it could remove inhibitors of RasP
such as peptides from the membrane either into the cytoplasm or
the extracellular medium.
Staphylococcus aureus strains resistant to multiple antibiotics are
increasingly common causes of serious and problematic infections
both in hospitals and communities [12,13]. The pleiotropic
phenotype of B. subtilis ecs mutants suggests that Ecs could be
important for virulence in Gram-positive pathogens such as S.
aureus. We constructed two null mutations of S. aureus ecsAB and
studied their effects on virulence in a murine arthritis model [14],
performed a DNA microarray analysis to assess the effects of an ecs
mutation on global gene expression, determined antimicrobial
susceptibilities of an ecs mutant and characterized the mutant
phenotype also more generally. The mutant phenotype clarifies
the functional role of Ecs in S. aureus and other gram-positive
bacteria as well as the potentiality as a novel target for
antimicrobial drug development.
Results
Construction of the ecsAB mutant strains
The S. aureus ecsAB operon (ORFs NWMN_1728 and
NWMN_1727 in the Newman strain, respectively) was identified
with sequence similarity of the deduced amino acid sequences of
EcsA and EcsB proteins with the corresponding Ecs proteins of B.
subtilis, as well as with the conserved localization of the operon in the
genome close to the gene (NWMN_1729) encoding a Hit-family
protein. In order to study the functional role of the Ecs ABC
transporter in S. aureus, we constructed two null mutations of the
ecsAB operon, one which deleted large parts of both ecsA and ecsB
genes (DecsAB) and another one which inserted about a 0.9 kb
TargeTron intron fragment into ecsA (ecsA::intron) (see Materials
and Methods). The DecsAB (RH7636) and ecsA::intron (RH7783)
mutations are in the S. aureus LS-1 [14] and Newman [15] strains
respectively. We used these two mutants to study phenotypic effects
of Ecs inactivation. We also constructed the pKTH3832 plasmid
which carries the ecsAB operon in the pEPSA5 vector under
transcriptional control of the xylose-inducible T5X promoter [16].
pKTH3832 was used to complement ecs mutation and verify the
Ecs-dependency of some of the observed phenotypes.
Growth, autolysis and lysostaphin sensitivity of S. aureus
ecs mutant
Cultivation of the ecs mutants in BHI medium with a Bioscreen
apparatus suggested that Ecs deficiency has a slight effect on
growth. A difference in onset of growth was seen repeatedly with
ecsA::intron mutant and wild-type Newman strain (Figure 1A).
Otherwise the mutant grew in a similar manner as the wild-type
strain throughout the exponential growth phase. The LS-1 strain
was observed to grow more slowly and produce lower final optical
densities as compared to the Newman strain in the same growth
conditions (Figure 1A). However, the DecsAB mutant grew in a
similar manner as the ecsA::intron mutant exhibiting no reduction
in the stationary phase optical density and only a slight delay in the
growth onset as compared to the parental LS-1 strain.
We also examined whether the absence of Ecs affects autolysis
and sensitivity to lysostaphin (see Materials and Methods for the
assays). Autolytic activity of the cultures was found to be
dependent on the growth phase from which cells were harvested
for the assay (Figure 1B). Variation of results with actively growing
cells was significant and, if anything, it was observed that Ecs
deficiency slightly inhibited autolysis of cells during the exponen-
tial phase. In contrast, it was consistently seen that the absence of
Ecs increased autolytic activity of mature stationary-phase cells.
The ecsA::intron mutant is also more sensitive to lysostaphin
(Figure 1C). Both phenotypes were complemented by pKTH3832,
indicating that they are caused by the Ecs deficiency (the
complementation of the lysostaphin sensitivity is shown in
Figure 1C). These results suggest that Ecs transporter is important
for the normal structure and/or function of the cell wall.
Levels of cell wall proteins are decreased in the
ecsA::intron mutant
The cell wall defect of ecs mutant suggested by the above results
may also be manifested as changed levels of cell wall-associated
proteins. Therefore, we determined amounts of three cell wall
proteins in the ecsA::intron mutant and the wild-type strain by
immunoblotting. The determined proteins are Protein A (Spa),
IsdA iron-regulated heme-iron binding protein and ClfB clumping
factor B precursor. Protein A could be detected with specific
monoclonal mouse antibodies raised against Protein A. It was
found that ecsA::intron mutation clearly decreased Protein A levels
in the wall (about 3-fold as compared to the wild-type strain;
Figure 2A). Transcriptome data (see below) showed that this
decrease is at least partly caused by a decrease in spa gene
transcription. The levels of IsdA and ClfB proteins were also lower
in the wall of the mutant (grown in iron-sufficient BHI medium),
but the difference was less marked (Figure 2A). pKTH3832
restored wild-type levels of the three proteins, indicating that their
decrease was dependent on Ecs. Furthermore, since the expression
and subcellular distribution of IsdA is regulated by iron availability
[17], we also studied the effect of ecsA::intron on IsdA level in iron-
depleted BHI medium. The ecs mutant grew slower than the wild-
type Newman strain in this modified medium (data not shown),
but we could prepare whole cell, lysostaphin protoplast and cell
wall samples from the cells at the culture density of Klett 60 and
Ecs Transporter of S. aureus
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perform the analysis. Immunoblotting showed that IsdA levels
were clearly lower in all these samples as compared to the
corresponding ones of the wild-type strain (Figure 2B). These
results indicate that levels of at least some cell wall proteins are
dependent on Ecs and further corroborate the functional role of
Ecs in the cell wall.
EcsAB-dependent accumulation of overexpressed
staphylokinase precursor in the cell wall
In B. subtilis, Ecs inactivation impairs signal peptide processing
and secretion of overexpressed secretory proteins. This phenotype
is particularly clear with the heterologous Bacillus amyloliquefaciens
AmyQ a-amylase [8,9]. We wanted to find out whether absence of
EcsAB causes a similar protein secretion defect in S. aureus. As a
model secretory protein we used staphylokinase modified with C-
terminal Myc-tag (Sak-Myc). The Sak-Myc protein was overex-
pressed from pKTH3834, a derivative of pEPSA5 carrying the sak-
myc gene under the control of PT5X, by inducing with 0.5% xylose.
The secretion and processing of Sak-Myc was also studied at a
lower expression level induced with 0.02% xylose. The expression
was induced at the cell density of Klett 70 and samples for
immunoblotting were taken at Klett 200. The wild-type strain
grew from Klett 70 to Klett 200 in one hour and the ecsA::intron
mutant in two hours, indicating that overexpression of a secretory
protein causes severe stress and growth inhibition in the mutant.
Staphylokinase levels in whole cells, lysostaphin protoplasts,
protoplast supernatant and culture supernatant were analyzed by
immunoblotting with anti-Myc antibodies.
In both wild-type strain and ecsA::intron mutant, two forms of
Myc-tagged staphylokinase, the preSak-Myc precursor and mature
Sak-Myc, were detected (Figure 2C). The level of mature Sak-Myc
was similar in these strains or even slightly higher in the mutant
(whole cells and protoplasts), but the precursor level was lower in
the mutant (whole cells). In protoplast supernatants containing the
cell wall material, a clear difference was observed between the two
strains. Surprisingly, in the wild-type strain, an abundant amount
of preSak-Myc was accumulated in the wall, whereas none was
detected in the protoplasts, suggesting that the precursor was
almost totally located in the cell wall. In contrast, only a very low
amount of preSak-Myc was detected in the corresponding cell wall
fraction of the mutant and no precursor was observed in the
protoplasts (Figure 2C). The ecs mutation also decreased slightly
the level of secreted mature Sak-Myc in the culture supernatant.
The same preparations were also immunoblotted with antibodies
recognizing thioredoxin (TrxA) [18], a cytoplasmic protein, to
control protoplast stability, and ClfB [19], to control fractionation
of the subcellular fractions. In the case of wild-type strain, TrxA
was detected in the whole cell and protoplast fractions in similar
amounts but not in the wall fraction, indicating that these
protoplasts were stable. There was some leakage of TrxA from the
protoplasts of the mutant suggesting that these cells are less stable.
We did not see any degradation band of preSak-Myc in the
samples implying that increased proteolytic degradation in the
mutant does not cause the difference in the preSak-Myc levels in
the walls. These results suggest that EcsAB may be directly or
indirectly involved in the release of preSak from the membrane
into the wall. The immunoblotting of ClfB suggested that
Figure 1. Growth, autolysis and lysostaphin sensitivity of S.
aureus ecs mutant. (A) Growth curves of S. aureus ecs mutants and
their wild-type parental strains in BHI growth medium as measured with
a Bioscreen C apparatus. Lines are averages of five overlapping
replicates of a single experiment. Repetition in standardized conditions
gives the same result. (B) Autolysis of cells over time. Circles mark S.
aureus cells harvested from the exponential growth phase (Klett 200–
250) and triangles cells harvested from stationary phase cultures (Klett
700–720). Data points are averages of nine overlapping replicates of the
same experiment. Samples from young cultures produced hyperbolic
autolysis curves with gradual growth phase-dependent procession
through shouldered curves to bent slopes of stationary phase cultures
shown here with triangles. Baselines recorded with lysis buffer were in
the range of 0.20 to 0.23 for these normalized curves. (C) Decrease in
optical density over time of cell suspensions of the ecsA::intron mutant
and the wild-type Newman strain treated with 10 mg ml21 lysostaphin.
Means of five determinations and error bars are shown.
doi:10.1371/journal.pone.0014209.g001
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staphylokinase overexpression enhanced the effect of ecs mutation
on ClfB level in the wall (Figure 2). There is probably competition
in the export pathway between preSak-Myc and ClfB, and the
export is somehow dependent on Ecs.
When Pxyl-sak-myc was expressed at a lower level (induction with
0.02% xylose), the pattern was similar, but the amounts of the
staphylokinase forms in whole cell, protoplast and cell wall
fractions of the mutant were lower than in the corresponding
fractions of the wild-type strain (Figure 2C). There was no
difference in the level of the secreted Sak-Myc.
Ecs might affect indirectly the export of cell wall proteins and
overexpressed preSak-Myc by modulating proton motive force
(pmf). Therefore, we studied whether ecsA::intron mutation altered
pmf. The ecsA::intron mutant and wild-type Newman strain
showed a similar pmf as monitored with the fluorescent dye
diSC3(5) (data not shown), indicating that the pleitropic phenotype
of the mutant is not an indirect effect of altered pmf.
Gene expression changes conferred by the ecsA::intron
mutation
The pleiotropic phenotype of the ecs null mutant suggests that
an Ecs defect causes major changes in global gene expression. We
used DNA microarray to analyze Ecs-dependent changes in the
transcriptome. The analysis was performed with the ecsA::intron
mutant and the wild-type S. aureus Newman strain at two different
growth phases: late exponential (3 h) and early stationary (6 h)
phases.
At medium stringency of the analysis around 7% (3 h) and 10%
(6 h) of the transcriptomes were differentially expressed in the
ecsA::intron mutant as compared to the wild-type strain. The
growth time had a significant impact on the transcriptome; 30–
35% of the differentially-expressed genes were present in both lists
(Figure S1, Table S1 and Table S2). A prominent feature of the
transcriptome was the induction or repression of numerous genes
(n = 64) encoding transporter proteins, particularly ABC-type
transporters and PTS systems (Table 1). The fold changes of
transporter gene expression were mostly around 2, but several
higher differences were also observed. In particular, the lacF gene,
which encodes a PTS system lactose-specific IIA component, was
strongly repressed in the ecsA::intron mutant with almost a 20- and
40-fold difference at 3 h and 6 h, respectively. Since ecsA::intron is
an insertion at the position 309/310 in the 738 bp ecsA gene, the
oligonucleotide array used in the analysis detected the truncated
ecsA’ mRNA (MWNM_1728), but its level was reduced compared
to the wild-type ecsA mRNA. The expression change of 36 genes
(excluding ecsAB) was more than 4-fold at least in either of the two
growth phases (Table 2). Most of these strongly differentially
expressed genes were induced in the ecsA::intron mutant; only
eight were repressed. Interesting, NMWN_0903 encoding a
functionally unknown ABC transporter was repressed in the late
exponential phase but strongly induced in the early stationary
phase. The whole capsular polysaccharide biosynthesis operon cap
was induced 2 to 5 fold in the mutant (Table 2, Table S1 and
Table S2). The Ecs defect also affected the expression of genes
involved in the biosynthesis of the cell wall and ribosomes, and
numerous genes with a role in virulence. The NWMN_1655 gene,
which encodes the virulence factor regulator protein Rot, was
expressed at decreased levels (about 3-fold) in the ecsA::intron
mutant at both growth phases. Since Rot is a positive regulator of
Figure 2. Effect of Ecs deficiency on exported proteins. Levels of
three chromosomally-encoded cell wall proteins (Protein A, IsdA and
ClfB) and plasmid-encoded secretory protein (Myc-tagged staphyloki-
nase) in the ecsA::intron mutant and the parental Newman strain were
determined by immunoblotting. (A) The protein levels in protoplasts (P)
and protoplast supernatants containing the cell wall material (W) are
shown. The expression of Pxyl-ecsAB in the pKTH3832 plasmid was
induced with 0.02% xylose. The protein levels were quantitated by
determining optical densities of the protein bands and normalizing
them to the TrxA protein in the protoplasts. The normalized protein
amounts were adjusted so that the level in the wild-type Newman
strain is 100. (B) Levels of IsdA and TrxA in whole cells (Ce) of the
ecsA::intron mutant and the wild-type strain grown in iron-depleted BHI
medium, and in their protoplast and wall fractions. (C) Immunoblot
analysis of preSak-Myc and Sak-Myc levels in whole cells, protoplasts,
cell wall and culture supernatant (S). The expression of Pxyl-sak-myc in
the pKTH3834 plasmid was induced with 0.5% xyloxe (upper panels) or
0.02% xylose (lower panels). TrxA and ClfB levels in the same samples
(upper panels) were determined to control stability of the protoplasts
and fractionation of the cell wall, respectively. The supernatant samples
correspond to 8 ml, while the other samples are from 80 ml of the
cultures.
doi:10.1371/journal.pone.0014209.g002
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Table 1. Transporter systems differentially expressed in the ecsA::intron mutant.
Gene Transporter protein Fold change (wt/ecsA)
3 h 6 h
bsaF ABC transporter 1.8
cbiO cobalt transporter ATP-binding subunit 0.5
fhuG ferrichrome ABC transporter (permease) 0.6
glcA PTS system glucose-specific component 2.6
lacF PTS system lactose-specific IIA component 18.0 42.0
mnhD monovalent cation/H+ antiporter subunit D 1.9
NWMN_0048 drug transporter 2.0
NWMN_0136 PTS system component 2.7
NWMN_0153 maltose ABC transporter permease protein 2.7
NWMN_0154 maltose ABC transporter permease protein 2.5
NWMN_0199 PTS system IIA component 0.5
NWMN_0211 ABC transporter ATP-binding protein 1.9
NWMN_0343 ABC transporter ATP-binding protein 0.5
NWMN_0601 ABC transporter substrate-binding protein 1.8
NWMN_0602 iron (chelated) ABC transporter permease protein 1.8
NWMN_0688 ABC transporter ATP-binding protein 0.5
NWMN_0690 ABC transporter 1.9
NWMN_0691 amino acid ABC transporter permease protein 1.9
NWMN_0696 di-/tripeptide ABC transporter 1.9
NWMN_0861 oligopeptide ABC transporter substrate-binding protein 0.4
NWMN_0863 oligopeptide ABC transporter ATP-binding protein 0.2
NWMN_0903 ABC transporter ATP-binding protein 2.3 0.1
NWMN_0943 cobalt transport 2.2
NWMN_0968 spermidine/putrescine ABC transporter binding protein 1.8
NWMN_1231 ABC transporter ATP-binding protein 0.4 0.5
NWMN_1261 glycine betaine transporter 1.8
NWMN_1291 peptide ABC transporter ATP-binding protein 0.6
NWMN_1292 oligopeptide transporter permease 0.5
NWMN_1293 oligopeptide transporter permease 0.6
NWMN_1458 ABC transporter permease 0.5
NWMN_1540 preprotein translocase YajC subunit 2.7
NWMN_1728 ABC transporter ATP-binding protein 2.2 7.0
NWMN_1749 amino acid ABC transporter ATP-binding protein 3.1
NWMN_1763 ABC transporter ATP-binding protein 2.1
NWMN_1867 ABC transporter ATP-binding protein 1.8
NWMN_1950 ammonium transporter 0.4
NWMN_2050 cation efflux 0.5 0.5
NWMN_2076 FecCD iron compound ABC transporter permease 0.5
NWMN_2081 transporter 0.2
NWMN_2089 BCCT family osmoprotectant transporter 2.1
NWMN_2224 PTS system component 2.1 1.8
NWMN_2246 sodium/glutamate symporter 2.5 2.4
NWMN_2261 ABC transporter ATP-binding protein HtrB 2.2
NWMN_2268 L-lactate permease 3.0
NWMN_2279 PTS system sucrose-specific IIBC component 2.4
NWMN_2311 amino acid ABC transporter ATP-binding protein 2.0
NWMN_2343 drug transporter 0.5
NWMN_2349 amino acid permease 0.6
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s-
pa gene expression [20], the down-regulation may explain why spa
was expressed at strongly decreased levels (17-25-fold) in the
mutant. The decreased spa expression is consistent with the
decreased Protein A level in the wall of the mutant (see above).
The sdrC and sdrD genes, which are required for adherence of S.
aureus Newman to squamous epithelium in the anterior nares [19],
were repressed in the null mutant. Furthermore, several genes
encoding Spl serine proteases, superantigen-like proteins, accesso-
ry regulators, SsaA secretory antigens, staphylokinase, fibrinogen-
binding proteins and a fibronectin-binding protein were differen-
tially expressed (Table S1 and Table S2).
The effects of Ecs deficiency on the structure of bacterial
surface
The induction of the capsular polysaccharide operon in
ecsA::intron mutant (DNA microarray analysis above) suggested
that the mutant might have a thicker capsule than the wild-type
Newman strain. However, Indian ink-crystal violet staining of the
capsule did not reveal increased amounts of capsule material in the
mutant but rather suggested that ecs mutant cells are smaller than
wild-type cells (data not shown). This was further studied by using
electron microscopy, but the resulting images did not confirm the
cell size difference. Instead, Ecs deficiency was found to alter cell
surface. Wild-type Newman cells looked slightly fluffy by scanning
electron microscopy, whereas ecs mutant cells were smoother
(Figure 3). Accordingly, poorly defined, loose outer surface
structure of the Newman strain and more sharply defined,
compact surface structure of the ecsA::intron mutant were seen in
transmission electron micrographs (Figure 3). Transformation of
the mutant with pKTH3832 restored the wild type-like surface
structure when Pxyl-ecsAB was induced at a low level (not shown),
indicating that the phenotype was complemented. The surface
change of the mutant may explain why crystal violet-stained ecs
mutant cells looked optically smaller than corresponding wild-type
cells. The surface change is also consistent with the other results
above (Figure 1A) showing that Ecs deficiency causes a growth
defect as measured spectrophotometrically and has significant
effects on the cell wall. Similarly, electron microscopy of LS-1 and
the corresponding DescAB mutant strains revealed thicker cell wall
and a minor change in surface structure which is consistent with
the results in Figure 1A (data not shown).
Ecs deficiency attenuated staphylococcal infection in
mice
The importance of the ecs for S. aureus virulence during in vivo
infection was studied in a mouse model of S. aureus arthritis [14].
Healthy mice were inoculated with ecsmutant or wild-type strain in
four independent experiments (Table S3). Staphylococcal infection
was followed by clinical signs as weight loss, mortality and frequency
of arthritis. The results were consistent in all experiments and
showed that mice infected with ecs mutant had significantly less
weight loss, mortality and lower frequency and severity of clinically-
assessed arthritis as compared with the mice inoculated with wild-
type strain (Figure 4A–D). In addition, histological evaluation of
joints obtained at days 3 and 17 revealed that the DecsAB mutant
caused milder synovitis and less bone erosions than the LS-1 strain
(Fig. 4E). Inoculation of the ecsA::intron mutant and wild-type
Newman strains supported the results obtained in the infection with
DecsABmutant and wild-type LS-1 strains with respect to weight loss
and frequency of arthritis (data not shown).
The ability of the ecs mutants to persist in the infected mice was
studied by determining bacterial counts in kidneys obtained at
days 3, 14 and 17 after bacterial inoculation (Table S3). Both ecs
mutant strains had a significantly reduced capacity to persist in
kidneys at the late phase of the infection (day 17), while the
capacity at the early phase of the infection (day 3) was similar with
the wild-type strains. The systemic inflammatory response induced
by the ecs mutant and wild-type strains was assessed by the serum
levels of IL-6. The DecsAB mutant strain induced similar levels of
IL-6 as the wild-type LS-1 strain, both on day 3 (pg/ml: 529 [400
to 1919] versus 773 [504–2750]) and on day 17 (pg/ml: 165 [100–
312] versus 256 [150–344]).
Gene Transporter protein Fold change (wt/ecsA)
3 h 6 h
NWMN_2370 transporter 0.5 0.5
NWMN_2412 ABC transporter ATP-binding protein 1.9
NWMN_2413 ABC transporter permease 4.5
NWMN_2458 cation transporter E1-E2 family ATPase 1.8 2.6
NWMN_2521 permease domain-containing protein 2.0
NWMN_2540 PTS system fructose-specific IIABC component 0.5
NWMN_2592 sodium sulfate symporter 1.8
NWMN_2593 RarD protein 3.5
opp1F peptide ABC transporter ATP-binding protein 2.2
opuCD amino acid ABC transporter permease protein 2.0
pstB phosphate ABC transporter ATP-binding protein 0.6 2.1
ptsG PTS system glucose-specific IIABC component 1.9 0.3
sirB ABC transporter permease protein SirB 1.8
tatA mttA/Hcf106 -related protein 0.5
uhpT sugar phosphate antiporter 2.6
ulaA ascorbate-specific PTS system enzyme IIC 1.8 2.7
doi:10.1371/journal.pone.0014209.t001
Table 1. cont.
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The DecsAB mutant is protected from the bactericidal
effect of a-defensins
We investigated if the decreased virulence of the ecsmutants could
be explained by increased sensitivity to host antibacterial defensins.
The bactericidal effect of a-defensin HNP-2 was evaluated using
wild-type LS-1 and DecsABmutant strains. HNP-2 at concentrations
1–5–10 mg/ml showed a dose and time dependent bactericidal
effect on both wild-type and DecsAB strains. The DecsABmutant was
less sensitive to the bactericidal effect of HNP-2 at all concentrations
of staphylococci (Figure 5). In the presence of 5 mg/ml of HNP-2,
the bacterial counts of DecsAB mutant were 2–4 times higher as
compared to wild-type LS-1 strain.
Increased susceptibility of the ecsA::intron mutant to
ribosomal antibiotics and chelerythrine and sanguinarine
plant alkaloids
To explore further potential phenotypes of ecs mutant, a
phenotype microarray analysis (Biolog) was carried out with 20
different 90-well microtiter plates that tested susceptibility of the
mutant (ecsA::intron) to numerous antimicrobial agents and stress
Table 2. Genes induced or repressed more than 4-fold in the ecsA::intron mutant.
Gene Protein
Fold change
(wt/ecsA)
3 h 6 h
capB capsular polysaccharide biosynthesis protein CapB 0.2 0.5
capC capsular polysaccharide biosynthesis protein CapC 0.2 0.4
capG capsular polysaccharide biosynthesis protein CapG 0.3 0.2
capI capsular polysaccharide biosynthesis protein CapI 0.3 0.2
fbp fructose-1,6-bisphosphatase 4.4
gapB glyceraldehyde 3-phosphate dehydrogenase 2 4.9
hisD histidinol dehydrogenase 0.2 0.3
hisZ ATP phosphoribosyltransferase regulatory subunit 0.0 0.2
lacF PTS system lactose-specific IIA component 18.0 42.0
lukE leukotoxin LukE 0.1
NWMN_0074 glycosyl transferase group 1 0.2
NWMN_0353 ParB family chromosome partioning protein 4.1
NWMN_0542 VraX (SAS016) 0.2
NWMN_0863 oligopeptide ABC transporter ATP-binding protein 0.2
NWMN_0903 ABC transporter ATP-binding protein 2.3 0.1
NWMN_0995 bacteriophage L54a antirepressor 0.2
NWMN_1223 hypothetical protein 0.1
NWMN_1252 hypothetical protein 0.2
NWMN_1445 hypothetical protein 0.2
NWMN_1623 transglycosylase domain-containing protein 4.6
NWMN_1690 hypothetical protein 4.6
NWMN_1728 ABC transporter ATP-binding protein EcsA 2.2 7.0
NWMN_1889 hypothetical protein 0.2
NWMN_1893 phage head-tail adaptor 0.1
NWMN_2043 general stress protein 20U 0.2
NWMN_2081 hypothetical protein 0.2
NWMN_2199 secretory antigen SsaA 0.2 0.2
NWMN_2203 secretory antigen SsaA 0.2 0.2
NWMN_2468 acetyltransferase GNAT 0.2
phoB alkaline phosphatase III 0.2
pnp purine nucleoside phosphorylase 5.3
pyrAA carbamoyl phosphate synthase small subunit 0.1
pyrB aspartate carbamoyltransferase catalytic subunit 0.2
pyrC dihydroorotase 0.2
set3nm superantigen-like protein 0.2
spa protein A 17.4 25.1
trpE anthranilate synthase component I 0.1 0.1
doi:10.1371/journal.pone.0014209.t002
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conditions, and the ability to grow on various nutrients. In Biolog
phenotype microarrays, reduction of the tetrazolium indicator dye
is measured as a response to general metabolic activity of cells.
This kind of phenotype screen may reveal molecules that affect the
same cellular functions as Ecs and result in identification of new
lead molecules for antimicrobial development.
The analysis suggested that ecsA::intron mutation increased the
susceptibility to several antimicrobial agents (Figure S2). The
ecsA::intron mutant appeared to be more sensitive to chloram-
phenicol, sisomicin, tobramycin and paromomycin, which are
ribosomal antibiotics that inhibit protein synthesis, than the wild-
type strain. The mutation also increased the susceptibility to
antimicrobial agents other than antibiotics. Two plant alkaloids,
chelerythrine and sanguiranine, and some drugs and chemicals
with antimicrobial activity, including atropine, amitriptyline,
ethylene glycol, lipoic acid, orphenatrine, phenylarsine oxide,
DL-propranolol and thioridazine, inhibited the ecs mutant at lower
concentrations than the wild-type strain. A minor defect was also
observed in the mutant’s ability to utilize glutamate/glutamine-
containing dipeptides as a sole nitrogen source.
To further examine the Biolog findings we determined the
minimal inhibitory concentrations (MICs) of a number of the
Biolog-identified antimicrobial agents in Bioscreen growth exper-
iments. The MIC determinations were performed by cultivating
the two strains in BHI medium on Bioscreen plates with additives
and measuring optical densities, i.e. growth, of the cultures (see
Materials and Methods for details). Consistently with the
phenotype microarray data, ecsA::intron clearly decreased MICs
of the ribosomal antibiotics tobramycin, sisomycin and chloram-
phenicol (Table 3). Susceptibility of the mutant to chelerythrine
and sanguinarine was also increased (about 2-fold difference in
MICs), while no significant differences were observed in the
sensitivity to amitriptyline, chlorpromazine, lipoic acid, phenylar-
sine oxide, DL-propranolol or thioridazine.
Discussion
In this study we mutated the ecsAB genes of S. aureus and
characterized the changes in transcriptome profile, phenotype and
functional properties of staphylococci in relation to this mutation
including in vivo evaluation of virulence. We show that the EcsAB
transporter is dispensable for growth but critical for virulence and
thus may be a potential novel antimicrobial drug target.
Results obtained in the mouse model of hematogenous
staphylococcal infection show that the Ecs deficiency attenuates
all signs of infection including weight loss, persistence of bacteria in
kidneys, frequency and severity of arthritis and bone destruction,
and finally results in a significant reduction in mortality. The
identical findings obtained in the experiments using two different
types of ecs mutations and two host strains strongly imply that the
observed attenuated virulence was caused by the absence of Ecs.
Another way of confirming this would be to use a complemented
mutant strain. However, due to known difficulties in controlling
plasmid maintenance during in vivo infection this option was not
used in our study.
We evaluated the mechanisms leading to the decreased
virulence of the ecs mutants. The expression profile of transporter
Figure 4. Weight change, mortality and arthritis during in vivo S. aureus infection in mice. (A) Weight change, (B) mortality, (C) frequency
of arthritis, and (D) severity of clinically assessed arthritis in mice inoculated with the DecsAB mutant or LS-1 wild-type S. aureus strain. (E)
Histopathological evaluation of synovitis and joint erosion at day 3 and 17 after bacterial inoculation. Bars show means 6 SEM. Horizonal lines
indicate medians. Open circles DecsAB, closed circles LS-1. *P,0.05; **P,0.01; ***P,0.001.
doi:10.1371/journal.pone.0014209.g004
Figure 3. Effect of Ecs deficiency on cell surface texture.
Scanning (left panels) and transmission (right panels) electron
microscope images of ecsA::intron mutant and wild-type Newman cells.
The scale bars 1 mm (left panels) and 0.5 mm (right panels). The
scanning electron micrographs show smoother surface texture of the
mutant as compared to the wild type but no significant difference in
cell size. The transmission electron micrographs suggest that on the
average cell surfaces of ecsA::intron mutant cells are more compact.
doi:10.1371/journal.pone.0014209.g003
Ecs Transporter of S. aureus
PLoS ONE | www.plosone.org 8 December 2010 | Volume 5 | Issue 12 | e14209
and adhesion proteins revealed significant changes in the
ecsA::intron mutant as compared to the wild-type strain. The
expression of the spa gene was strongly repressed (about 20 fold) in
the ecsA::intron mutant and the spa repression resulted in decreased
Protein A levels in the mutant. Protein A, mediating resistance to
opsonization and phagocytosis, is a known virulence factor in S.
aureus arthritis and sepsis [21] as well as in subcutaneous
experimental infections in mice [22]. Protein A is also involved
in S. aureus invasion of cultured epithelial cells [23] and
development of biofilm-associated infections [24]. The sdrC and
sdrD genes encoding virulence-related adhesins were down-
regulated in the ecsA::intron mutant. The expression of these
genes is positively regulated by the virulence factor regulator
protein Rot [25,26]. The rot gene is down-regulated in the
ecsA::intron mutant (2.7–3.5 fold) which may cause the down-
regulation of adhesins in the ecs mutant. The inability of the
ecsA::intron mutant to increase cellular level of the IsdA iron-
regulated heme-iron binding protein inder conditions in which
iron availability is limited may lead to impaired growth and
inability to cause severe infections. In the absence of Ecs,
significant changes occur in the cell wall, as evidenced by
increased autolysis and sensitivity to lysostaphin, altered cell
surface texture as well as decreased levels of cell wall proteins. All
these phenotypes are probably consequences of the main transport
defect in the membrane and may be reasons for the low virulence
of ecs mutants.
In a previous study, signal peptides of overexpressed secretory
proteins were found to be processed inefficiently in ecsmutants of B.
subtilis and increased levels of preAmyQ a-amylase precursor was
detected on the outer surface of the cell membrane, suggesting a
defect in a late stage of protein secretion [8]. We did not observe a
similar impaired signal peptide processing in the S. aureus ecsA::intron
mutant, rather an effect on the release from the membrane and
accumulation in the cell wall of preSak-Myc. The level of preSak-
Myc was low in the wall of the mutant, in contrast to its abundant
amount in the wall of the wild-type strain, which is consistent with
transport disability. The Myc-tagged staphylokinase was expressed
from the xylose-inducible T5X promoter, and its levels were similar
in the whole cells and in protoplasts of the two strains (induction
Figure 5. Bactericidal effect of a-defensin HNP-2 on S. aureus
LS-1 and its isogenic DecsABmutant. LS-1 and DecsAB mutant were
suspended in Todd-Hewitt broth in concentrations 103 cfu/ml (A), 104
cfu/ml (B), and 105 cfu/ml (C), and incubated with shaking in the
presence of HNP-2 (5 mg ml21) at 37uC. The results of 4 independent
experiments are summarized. Staphylococcal growth in the presence
and absence of HNP-2 was evaluated at determined time points and
given in percent, indicating bacterial killing effect of HNP-2. In the
tested bacterial concentrations, the bactericidal effect of HNP-2 was 2–4
times stronger on LS-1 as compared to DecsAB mutant.
doi:10.1371/journal.pone.0014209.g005
Table 3. Minimal inhibitory concentrations of selected
antimicrobial agents.
Antimicrobial agent MIC (mg ml21)
S. aureus
Newman
S. aureus
ecsA::intron
Phenylarsine oxide 7.5 5
Chelerythrine chloride 12.5 5
DL-Propranolol hydrochloride 400 350
Chlorpromazine hydrochloride 50 50
Lipoic acid 2000 1750
Amitriptyline hydrochloride 150 125
Thioridazine hydrochloride 20 15
Sanguinarine chloride hydrate 10 5
Chloramphenicol 4 2
Tobramycin 7.5 2.5
Sisomicin 5 1
Numbers are concentrations resulting in no growth in 16 h experiment. Three
replicates, each experiment repeated at least two times.
doi:10.1371/journal.pone.0014209.t003
Ecs Transporter of S. aureus
PLoS ONE | www.plosone.org 9 December 2010 | Volume 5 | Issue 12 | e14209
with 0.5% xylose). Thus, the difference in the accumulation of
preSak-Myc in the wall of ecsA::intron mutant and wild-type strains
is unlikely to be induced at the transcription level.
The B. subtilis sW anti-sigma factor RsiW and the FtsL cell
division protein are membrane proteins with single transmem-
brane segments which are processed inside the lipid bilayer of the
membrane by the RasP (YluC) intramembrane-cleaving protease
[11,27,28]. The processing of RsiW and FtsL is inhibited in ecs
mutants of B. subtilis [11]. One possible explanation for this
inhibition is that membrane-spanning peptides or proteins
accumulate in the membrane and competitively inhibit RasP. It
can be speculated that Ecs is involved in the removal and cleaning
of such peptides/proteins from the membrane. The finding that
the release of overexpressed preSak-Myc was decreased in the S.
aureus ecsA:.intron mutant as compared to the wild-type strain
suggests this kind of transport function for Ecs. In future studies
the transport function must be confirmed in a reconstituted system
with purified EcsAB proteins and peptide and preSak-Myc
substrates.
The inactivation of Ecs increased susceptibility of S. aureus to
several antimicrobial agents including ribosomal antibiotics as was
demonstrated by phenotype microarray analysis and MIC
determinations. The increased susceptibility may be related to
the altered expression of several genes encoding ribosomal proteins
observed in the DNA microarray. Interestingly, the ecs mutant was
also more sensitive to chelerythrine and sanguinarine plant
alkaloids. These alkaloids are antimicrobial compounds, but their
mode of antimicrobial action is unclear. We showed that DecsAB
mutation decreased susceptibility to HNP-2 a-defensin. a-
Defensins are antimicrobial peptides secreted by polymorphonu-
clear cells and involved in the first line of defense against invading
microbes [29]. HNP-2 is lethal to bacteria since it forms pores in
the cytoplasmic membrane [30,31]. This observation is unexpect-
ed taking into consideration the increased sensitivity of the
ecsA::intron mutant to autolysis, lysostaphin as well as to
antimicrobial agents. The mechanism of such a discrepancy needs
further evaluation.
It is still a mystery which molecule(s), if any, Ecs transports.
Since obligatory anaerobes or microaerophilic bacteria do not
have Ecs, the function of Ecs might be related to respiration. We
have performed experiments to find out whether Ecs transports
heme to cytochromes in B. subtilis. Cytochrome C-bound heme in
a null mutant of B. subtilis ecsAB and its wild-type parent was
labeled with 5-[4-14C]aminolevulinic acid and analyzed in SDS-
PAGE as has been described [32]. The result showed that Ecs is
not involved in heme transport (unpublished). In this study, we
showed with S. aureus that Ecs does not affect the proton motive
force either.
Our study shows that the Ecs deficiency attenuates staphylo-
coccal virulence and increases its sensitivity to antimicrobial
agents. This is probably a consequence of the defects in the
composition and function of the bacterial membrane and cell wall.
Materials and Methods
Ethics statement
Ethical permission (282-06) was obtained from the Animal
ethical committee of Go¨teborg, Sweden.
Bacterial strains and culture conditions
S. aureus strains used in this study are Newman [15], LS-1 [14]
and RN4220 (NCTC 8325-4 r-m+). Escherichia coli DH5a was used
for cloning. Staphylococci were grown in BHI (Brain Hearth
Infusion) medium and on corresponding agar plates if not
otherwise indicated. Iron-depleted BHI medium was prepared
by treating BHI with 5% Chelex 100 for 1 hour. E. coli was
cultivated in LB (Luria-Bertani) medium and on corresponding
agar plates. Growth media were supplemented with chloram-
phenicol (10 mg ml21), erythromycin (2.5 mg ml21) or ampicillin
(100 mg ml21) when needed to maintain plasmids in the strains.
Null mutations of ecsAB
In order to construct the DecsAB mutation, the plasmid
pKTH3726 was constructed. The ecs-deletion cassette in
pKTH3726 was constructed by PCR-amplifying two approxi-
mately 1 kb fragments, ecs-up and ecs-down, and fusing them by
ligating the SphI site in the 3’ end of ecs-up to the SphI site in the
5’ end of ecs-down. The primers used to amplify ecs-up were: ecs-
1, 5’ GGGGACCACTTTGTACAAGAAAGCTGGGTTTGSA-
AACTACCAAATTCCGCAC and ecs-2, 5’ GGAAGCATGC-
CAGGGCGTTTTTCCATATCCAC. The primers used to
amplify ecs-down were: ecs-3, 5’ GGAAGCATGCTCTCAATT-
TATGCGTCATGCG and ecs-4, 5’ GGGGACAAGTTTGTA-
CAAAAAAGCAGGCTCATTACTTTGGTTCAAGCGGAC.
pKTH3726 was obtained by inserting the ecs-deletion cassette
between the attB sites in the pKOR1 plasmid by using Clonase
(Invitrogen) as previously described [33]. The ecsAB operon
(SA1655 and SA1654, respectively) in the S. aureus strain LS-1
was disrupted by using pKTH3726 and the procedure described
previously [33,34]. The DecsAB mutation deleted the fragment
from the nucleotide +50 of ecsA (the first nucleotide of the
coding region is +1) to +285 of ecsB.
The ecsA::intron mutation was constructed by using the
TargeTron system (Sigma-Aldrich) with the vector plasmid
pNL9164 according to the instructions of the manufacturer. For
the re-targeting of the intron II RNA into ecsA, a 350 bp re-targeting
DNA fragment was amplified in a one step assembly PCR and
inserted into pNL9164. The primers used in the PCR were: 309/
310s-IBS; 5’ AAAAAAGCTTATAATTATCCTTAGCAATCG-
CATATGTGCGCCCAGATAGGGTG, 309/310s-EBS1d; 5’
CAGATTGTACAAATGTGGTGATAACAGATAAGTCGCA-
TATGATAACTTACCTTTCTTTGT, 309/310-EBS2; 5’ TGA-
ACGCAAGTTTCTAATTTCGATTATTGCTCGATAGAGG-
AAAGTGTCT and EBS Universal; 5’ CGAAATTAGAAACT-
TGCGTTCAGTAAAC.
Construction of plasmids for expression of EcsAB and
Myc-tagged staphylokinase
The pKTH3832 plasmid was constructed by PCR-amplifying a
fragment containing the ribosome-binding site and coding regions
of the ecsAB operon with the primers SaecsAB-fw and SaecsAB-rv
and inserting the fragment into the pEPSA5 plasmid [16] between
the SacI and BamHI sites. The primer sequences are: SaecsAB-fw; 5’
CACAGAGCTCCAATATAAGTCATGGAGGTGCCTTATG
and SaecsAB-rv; 5’ CACAGGATCCTTAGTCTCGTAATAAT-
GTTTCCTGATATTTCA.
The pKTH3834 plasmid was constructed in a similar manner as
pKTH3832 but the sak-myc fragment was inserted between the
EcoRI and BamHI sites in pEPSA5. The sak-myc fragment was PCR-
amplified with the primers sak-fw; 5’ CACAGAATTCTTA-
TATTTGGAGGAAGCGCCAT and sak-rv; 5’ CACAGGATCC-
TTACAGATCTTCTTCGCTGATCAGTTTCTGTTCTTTC-
TTTTCTATAATAACCTTTGTAATTAAGTTGAATCC.
Growth tests and susceptibility to antimicrobial agents
Growth of bacteria and determination of minimal inhibitory
concentrations (MICs) of different antimicrobial agents were
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performed using a Bioscreen C apparatus (Growth Curves,
Helsinki, Finland). For starting inocula, 5 ml of BHI medium
was inoculated with single colonies and grown for at least 20 h at
37uC with continuous shaking. Overnight cultures were then
diluted 1:30 in BHI medium and growth was monitored with Klett
Summerson colorimeter until early exponential growth phase.
Cultures were diluted 100 fold with BHI and a matrix of wells with
dilution series of the antimicrobial compounds in BHI were set up
on 100-well honeycomb plates (Growth Curves, Helsinki, Finland).
The inoculum was 15 ml and final volume 150 ml per well. Plates
were incubated for 16 h at 37uC with moderate continuous
shaking and growth was measured with a wide-band filter at
15 min intervals.
Autolysis and lysostaphin lysis assays
Autolysis of S. aureus cells was essentially tested as originally
described by de Jonge and collaborators [35], but lysis was
monitored with a Bioscreen apparatus. Inocula were grown as
described above for the growth experiments. Cultures were grown
to mid exponential or stationary growth phases and then
harvested, washed and resuspended in autolysis buffer. Samples
were diluted to an initial optical density (as measured in the
Bioscreen apparatus) of about 0.5 and volume of 150 ml. Decay of
cells was monitored as described above for growth with continuous
low level shaking.
Lysostaphin sensitivity was assayed as has been described
previously [36]. After adding 10 mg ml21 final concentration of
lysostaphin, bacterial lysis was monitored with the Bioscreen by
reading OD600 values at 2 min intervals.
Microscopy
Electron microscopy samples were prepared from exponential
phase cultures by adding 2.1% final concentration of glutaralde-
hyde to 5 ml of culture in a Parafilm M foil-secured 14 ml Falcon
polypropylene test tube (Becton Dickinson). To enhance fixation
tubes were slightly pressurized by injecting them with 1 ml of air
through the sealed cap using a small needle, followed by
incubation overnight at 20–22uC. The fixed cells were washed
twice in phosphate buffer and then treated with 1% osmium
tetroxide for 1 h. The samples were dehydrated with a series of
treatments with ethanol and acetone, followed by embedding in
Epon resin. The transmission and scanning electron microscopy
was performed in the Institute of Biotechnology, University of
Helsinki, by using JEOL 1200EX II and Zeiss DSM-962 electron
microscopes, respectively.
Immunoblot analysis of cell wall proteins and preSak-Myc
Protoplast and cell wall subcellular fractions were isolated by
harvesting cells from 1 ml of culture and incubating the cells in
0.1 ml of the protoplast buffer (20 mM potassium phosphate
pH 7.5, 15 mM MgCl2 and 20% sucrose) containing 0.1 mg/ml
lysostaphin for 30 min at 37uC, followed by centrifugation at
5,000 rpm in an Eppendorf miniSpin Plus centrifuge for 10 min.
The protoplast pellet was resuspended in 0.1 ml of protoplast
buffer, followed by adding 25 ml of 56Laemmli sample buffer to
the protoplast fraction as well as the protoplast supernatant (cell
wall fraction) and heating for 10 min at 100uC. Whole cell
fractions were prepared in a similar manner but the centrifugation
step was omitted. Proteins in 10 ml samples were separated in
SDS-PAGE and analyzed by immunoblotting with specific
antibodies. Cell wall proteins were detected with rabbit antibodies
and Protein A-peroxidase (Sigma-Aldrich). Myc-tagged staphylo-
kinase was detected with HRP-conjugated mouse anti-Myc
antibodies (ab62928) from Abcam. ECL reactions were performed
using an Immun-Star WesternC kit (Bio-Rad) and proteins were
visualized and quantitated with a FluorChem HD2 imager and
AlphaEase FC software (AlphaInnotech).
Mouse model of S. aureus arthritis
Six to eight weeks old female NMRI mice (Scandbur, Uppsala,
Sweden or from Charles River Laboratories, Sullzfeld, Germany)
were used. Mice were maintained in the animal facility of the
Department of Rheumatology and Inflammation Research,
University of Gothenburg, Sweden, housed under standard
conditions of temperature and light, and fed standard laboratory
chow and water ad libitum. Ethical permission was obtained from
the Animal ethical committee of Go¨teborg, Sweden.
Mice were inoculated intravenously into the tail vein with 6.4–
76106 colony forming units (CFU) of the wild-type LS-1 strain
(n = 35) or 6.6–96106 CFU of the DecsAB mutant strain (n = 35) in
a total volume of 200 ml of phosphate-buffered saline (PBS). Before
inoculation, aliquots of bacteria frozen in PBS containing 5%
bovine serum albumin w/v (BSA) and 10% v/v dimethyl sulfoxide
(DMSO) after over night culture on horse blood agar plates
overnight followed by transfer to fresh agar plates and incubation
for an additional 24 h period were thawed, washed, diluted in
PBS, and adjusted to the appropriate concentration. Viable counts
were performed to determine the number of bacteria injected in
each experiment.
Mice were also inoculated as described above with 5.96106
CFU of the wild-type Newman strain (n = 10) or 6.66106 CFU of
the isogenic ecsA::intron mutant strain (n = 10).
Mortality was recorded and all mice were weighted and graded
blindly by one observer (I-M J) for arthritis severity and frequency
at regular intervals. Finger/toe and wrist/ankle joints were
inspected visually for signs of arthritis defined as erythema and
or swelling. Arthritis was scored from 0 to 3 points for each limb
(0= normal appearance; 1 =mild swelling and/or erythema;
2 =moderate swelling and erythema; 3=marked swelling and
erythema).
Blood, limbs and kidneys were taken at day 3, 14 and 17 from
the DecsAB mutant and LS-1 strain inoculated mice.
Kidneys were taken at day 14 from ecsA::intron mutant strain
and Newman inoculated mice.
Histologic examination of joints
Histopathological evaluation of the joints was done after routine
paraformaldehyde fixation, decalcification, and paraffin embed-
ding. Tissue sections from fore- and hind-paws were stained with
hematoxylin and eosin and microscopically scored with regard to
synovial hypertrophy/infiltration of leukocytes and cartilage and
bone erosion, by an observer (I-M J) blinded to inoculation groups.
Synovitis and erosion of cartilage and/or bone was scored;
0 = normal appearance, 1 =mild synovitis and/or erosion of
cartilage and bone, 2=moderate synovitis and erosion of cartilage
and/or bone, 3= severe synovitis and erosion of cartilage and
bone.
Bacteriological examination of infected animals
The kidneys were aseptically removed, homogenized on ice,
serially diluted in PBS and spread on horse blood agar plates. The
number of CFU per kidney pair was determined after incubation
for 24 h at 37uC.
Serological analysis of IL-6 levels
The serum levels of interleukin-6 was determined using the
murine hybridoma cell line (B9) as previously described [37].
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Statistical analyses of the mouse infections
Statistical analyses were performed by using the GraphPad
Prism (LaJolla, CA). Statistical differences between independent
groups were calculated using Mann-Whitney U test or Fischer’s
exact probability test. Kaplan-Meier survival plots were prepared
and the log-rank test was used for comparison between survival
curves. P-values ,0.05 were considered as statistically significant.
Influence of a-defensins on growth of the isogenic S.
aureus strains
LS-1 and its isogenic DecsAB mutant were suspended in Todd-
Hewitt broth (THB) in concentrations 103, 104, and 105 cfu/ml,
and incubated shaking with human neutrophil peptide-2 (HNP-2,
Bachem, Finechemikalien AG, Switzerland) at a range of 0–10 mg
ml21 at 37uC. At determined time points, 0.1 ml of the cultures
were spread on blood agar plates and incubated over night at
37uC. The number of staphylococcal colonies were counted and
compared between LS-1 and DecsAB strains. To assess the effect of
HNP-2 on staphylococcal growth, reduction in cfu count of HNP-
2-treated cultures was compared to cfu count of untreated
cultures. The results are presented as percent of bacterial killing.
Phenotype microarray (PM) analysis
The PM analysis was carried out by using the service of Biolog
(Hayward, CA). The method has been described in other studies
[34,38].
Preparation of labeled nucleic acids for expression
microarrays
Total RNA was purified from bacteria grown in BHI for 3 or
6 h. The inocula were 50-fold dilutions from overnight cultures.
For each strain, RNA of four independently grown cultures was
analyzed. After an additional DNase treatment, the absence of
remaining DNA traces was confirmed by quantitative PCR (SDS
7700; Applied Biosystems, Framingham, MA) with assays specific
for 16S rRNA [39]. Batches of 5 mg of total S. aureus RNA were
labeled with Cy3-dCTP (RH7783) or Cy5-dCTP (RH7603) using
SuperScript II (Invitrogen, Basel, Switzerland) following manu-
facturer’s instructions. Labeled products were then purified on
QiaQuick columns (Qiagen). A mixture of Cy-3 and Cy-5 labeled
products (250 ng) were mixed for each time point, diluted in 60 ml
Agilent hybridization buffer, and hybridized at a temperature of
60uC for 17 hours in a dedicated hybridization oven (Robbins
Scientific, Sunnyvale, CA). Slides were washed with Agilent
proprietary buffers, dried under nitrogen flow, and scanned using
100% PMT power for both wavelengths.
Microarray analysis
Fluorescence intensities were extracted using Feature Extraction
software (version 8; Agilent). Local background-subtracted signals
were corrected for unequal dye incorporation or unequal load of
the labeled product. The algorithm consisted of a rank consistency
filter and a curve fit using the default LOWESS (locally weighted
linear regression) method. Data consisting of two independent
biological experiments were expressed as log 10 ratios and
analyzed using GeneSpring, version 8.0 (Silicon Genetics,
Redwood City, CA). Statistical significance of differentially
expressed genes was calculated by analysis of variance [40] using
GeneSpring, including the Benjamini and Hochberg false
discovery rate correction of 5% (P value cutoff, 0.05) and an
arbitrary cutoff of twofold for expression ratios.
Microarray data accession number
Microarray design has been described previously [39]. The
complete microarray data set has been posted on the Gene
Expression Omnibus database (http://www.ncbi.nlm.nih.gov/
geo/) under accession number GPL10537 for the platform design
and GSE22353 for the original data set.
Supporting Information
Figure S1 Two-way clustering analysis of S. aureus transcrip-
tomic patterns. Expression microarrays (normalized data) were
clustered by a hierarchical clustering algorithm by using an
average linkage method in GeneSpring. The expression values for
a gene across all samples were standardized to have mean of 0 and
standard deviation of 1 by linear transformation. To determine the
amount of detectable genes, the expression values were averaged
for transcripts mapped by 2 or more probes. A cut-off value
defined as 2 x standard deviation obtained for background
intensities was then applied.The figure shows a clear separation of
4 sub-clusters containing 4 replicate experiments (1-4) for each
time-point and for the WT (RH7603) or the mutant strain
(RH7783). Each probe set is represented by a single row of colored
boxes and each sample corresponds to a single column. The blue
areas correspond to genes showing high or medium expression
whereas yellow bars indicates genes poorly or not expressed. The
dendrogram (green lines) on the top of the figure represents the
similarity matrix of probe sets.
Found at: doi:10.1371/journal.pone.0014209.s001 (3.51MBDOC)
Figure S2 Phenotype microarray analysis of the ecsA::intron
mutant. Antimicrobial sensitivities of RH7783 (ecsA::intron) and
RH7603 (S. aureus Newman) were compared by using phenotype
microarrays. Scatter plots of parameter values from two replicates
of the PM analysis are shown in the two uppermost panels. Three
other panels show overlaid color-coded images of tetrazolium
reduction kinetics (mutant versus wild type) over all wells in the
two runs of the analysis and their consensus. Phenotypes observed
are listed below the figure panels.
Found at: doi:10.1371/journal.pone.0014209.s002 (5.70 MB RTF)
Table S1 Genes induced or repressed in cells of the ecsA::intron
mutant in the late exponential growth phase (3h) as compared to
the wild-type Newman strain.
Found at: doi:10.1371/journal.pone.0014209.s003 (0.07 MB XLS)
Table S2 Genes induced or repressed in cells of the ecsA::intron
mutant in the early stationary growth phase (6h) as compared to
the wild-type Newman strain.
Found at: doi:10.1371/journal.pone.0014209.s004 (0.08 MB XLS)
Table S3 Persistence of ecs mutant and wild-type S. aureus cells in
kidneys.
Found at: doi:10.1371/journal.pone.0014209.s005 (0.04 MB RTF)
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